Brenntag (BNR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Apr, 2026Executive summary
2025 was marked by the longest market downturn in over two decades, with persistent weak demand and declining volumes, especially in Q4.
Despite headwinds, gross profit margins improved and free cash flow remained strong, demonstrating margin resilience and robust cash generation.
Major organizational restructuring included removing divisional layers, forming a new executive committee, and reducing ~800 FTE to streamline decision-making.
Accelerated cost-out program delivered EUR 165 million in annual savings, with further savings targeted by 2027.
Dividend proposal of EUR 1.90 per share, reflecting a balanced approach amid extraordinary write-offs and strong cash flow.
Financial highlights
Revenue reached EUR 15.2 billion, down 3.7–4% year-over-year; Q4 organic sales down 5%.
Operating gross profit was EUR 3.8 billion, margin up to 25.3% (+0.5pp); operating EBITDA EUR 1,288 million (-8.6%), EBITA EUR 929 million (-12.6%).
Profit after tax attributable to shareholders was EUR 265–269.7 million, down over 50% year-over-year, mainly due to non-cash impairments and special items totaling EUR 248 million.
Free cash flow increased 5–5.4% to EUR 941 million, supported by working capital discipline and lower CapEx.
EPS dropped to EUR 1.83 (reported), or EUR 3.55 excluding one-offs.
Outlook and guidance
2026 Operating EBITDA guidance set at EUR 1.15–1.35 billion, reflecting continued macroeconomic challenges and no short-term improvement expected.
Guidance includes closed acquisitions, assumes stable FX, and excludes potential Middle East crisis impacts.
Further cost savings of EUR 200–250 million targeted by 2027 against a new 2025 baseline.
Strategic review and update planned for H2 2026.
Latest events from Brenntag
- Resilient FY 2024 performance with strong cash flow, cost-out, and sustainability leadership.BNR
Investor presentation12 Mar 2026 - Board renewal, enhanced remuneration, and ESG leadership drive governance excellence.BNR
Investor presentation17 Feb 2026 - Q2 and H1 2024 saw lower sales, EBITA, and cash flow, with guidance revised down.BNR
Q2 20241 Feb 2026 - Sales and gross profit rose, but EBITA, EPS, and free cash flow declined; guidance reaffirmed.BNR
Q3 202414 Jan 2026 - Sales and EBITA fell, but free cash flow and cost savings improved; guidance at lower end.BNR
Q3 202512 Dec 2025 - Sales and EBITDA fell, but cost savings and M&A support stability amid tough markets.BNR
Q4 20244 Dec 2025 - Stable Q1 sales and profit, but net income and cash flow declined amid global uncertainty.BNR
Q1 202524 Nov 2025 - Sales and EBITA declined, leading to a lower 2025 outlook amid persistent uncertainty.BNR
Q2 202523 Nov 2025 - Q2 2025 EBITA fell 13.9% as transformation, cost savings, and sustainability drive future growth.BNR
Investor Presentation13 Aug 2025